A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia

Amer M. Zeidan, B. Douglas Smith, Hetty E. Carraway, Ivana Gojo, Amy DeZern, Steven D. Gore

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences